Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Monica Caliber"'
Autor:
Farid Saad, Monica Caliber
Publikováno v:
Androgens: Clinical Research and Therapeutics. 1:40-61
Testosterone deficiency (TD) is common in men with obesity. The association between TD and obesity is bidirectional; low testosterone (T) is a contributing cause to obesity, and obesity is a contri...
Autor:
Aksam Yassin, Farid Saad, Monica Caliber, W. Timothy Garvey, Ahmad Haider, Karim Sultan Haider, Gheorghe Doros
Publikováno v:
Diabetes Care. 42:1104-1111
OBJECTIVE Type 2 diabetes (T2D) is a public health threat. Prediabetes represents a window of opportunity for intervention to prevent T2D. Men with T2D and prediabetes often have low testosterone. Since testosterone improves glycemic control in T2D,
Autor:
Monica Caliber, Abraham Morgentaler
Publikováno v:
Expert opinion on drug safety. 18(11)
Introduction: The use of testosterone therapy (TTh) in men with prostate cancer (PCa) is relatively new, and controversial, due to the longstanding maxim that TTh is contraindicated in men with PCa. Scientific advances have prompted a reevaluation of
Publikováno v:
The aging male : the official journal of the International Society for the Study of the Aging Male. 23(1)
Objective: The association between erectile dysfunction (ED), hypogonadism, cardiovascular disease, and type 2 diabetes is well documented, but long-term data are limited. The aim of this study is to investigate effects of long-term testosterone ther
Autor:
Geoffrey Hackett, Monica Caliber
Publikováno v:
The aging male : the official journal of the International Society for the Study of the Aging Male. 23(5)
In this commentary, we highlight important findings from a notable RCT by Ng Tang Fui et al. 2016 which investigated the effects of testosterone treatment in dieting obese men. First, a myopic focus on weight loss can detract from important improveme
Autor:
Abdulmaged M. Traish, Monica Caliber, Martin Miner, Mohit Khera, Abraham Morgentaler, André T. Guay
Publikováno v:
Mayo Clinic Proceedings. 90:224-251
Two recent studies raised new concerns regarding cardiovascular (CV) risks with testosterone (T) therapy. This article reviews those studies as well as the extensive literature on T and CV risks. A MEDLINE search was performed for the years 1940 to A